PUBLISHER: KBV Research | PRODUCT CODE: 1374194
PUBLISHER: KBV Research | PRODUCT CODE: 1374194
The Europe Moist Wound Dressings Market would witness market growth of 5.0% CAGR during the forecast period (2023-2030). In the year 2020, the Europe market's volume surged to 243.5 million Units, showcasing a growth of 4.9% (2019-2022).
The moist wound dressing stimulates collagen synthesis, alleviates discomfort, and encourages keratinocyte migration. Moist wound dressings promote three to five times more rapid healing than dry ones. Keratinocyte cells function more efficiently in a moist environment because they can reach the wound surface quickly. The moist climate generates a hypoxic wound bed, lowers the pH, promotes angiogenesis, and renders the wound bed inhospitable to bacteria. The presence of moisture facilitates topical treatment for tissue and cell transplants. As moist wound dressings play a crucial role in the treatment of both chronic and acute lesions, these factors are expected to drive market growth.
The market is anticipated to expand swiftly as optimally moist environments promote faster wound healing. According to estimates, moist wounds recover three to five times faster than dry wounds. Burns, traumatic injuries, pressure ulcers, venous leg ulcers, and ulcers from diabetes are some of the wound types treated with moist wound dressings. In addition, moist wound dressing accelerates keratinocyte activity, essential for wound healing. Moist healing of wounds stimulates the synthesis of collagen as moisture promotes the production of collagen by fibroblasts. Increased collagen production enables the body to lay down a matrix for new tissue more rapidly, resulting in accelerated healing. These factors will increase the market opportunity for moist wound dressings in the coming years.
Europe boasts well-established and advanced healthcare infrastructure, making it easier for healthcare facilities to adopt and implement innovative wound care solutions, including moist dressings. European regulatory agencies, like the European Medicines Agency (EMA) and national authorities, have stringent medical devices and wound care products standards. Europe attracts patients for medical treatment, including wound care. The availability of advanced wound care products, including moist dressings, can make Europe an attractive destination for patients seeking specialized care. Thus, all these elements will work in synergy to drive the growth of the regional market.
The Germany market dominated the Europe Moist Wound Dressings Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $404.8 million by 2030. The UK market is estimated to grow at a CAGR of 4.1% during (2023 - 2030). Additionally, The France market would exhibit a CAGR of 5.8% during (2023 - 2030).
Based on Application, the market is segmented into Chronic Wounds (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Others), and Acute Wounds (Surgical & Traumatic Wounds, and Burns). Based on End-use, the market is segmented into Hospitals, Specialty Clinics, Home Healthcare, and Others. Based on Product, the market is segmented into Foam Dressings, Film Dressings, Hydrogel Dressings, Alginate Dressings, Hydrocolloid Dressings, Collagen Dressings, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Coloplast Group, Medline Industries, Inc., Smith & Nephew PLC, Convatec, Inc., Essity AB, Integra LifeSciences Holdings Corporation, Cardinal Health, Inc., Molnlycke Health Care AB, 3M Company, B. Braun Melsungen AG
Market Segments covered in the Report:
By Application (Volume, Million Units, USD Million, 2019-2030)
By End-use (Volume, Million Units, USD Million, 2019-2030)
By Product (Volume, Million Units, USD Million, 2019-2030)
By Country (Volume, Million Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research